⌘K

Login Start Free

Home/Filings/4/0001288099-12-000001

4//SEC Filing

EHRLICH LEO 4

Accession 0001288099-12-000001

CIK 0001355250other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 12:27 PM ET

Size

14.7 KB

Accession

0001288099-12-000001

Insider Transaction Report

Form 4

Period: 2010-07-27

Cellceutix CORPCTIX

DirectorChief Executive Officer10% Owner

Transactions

AwardSwap
Stock Option (right to buy)
2010-12-29$0.11/sh+6,000,000$660,000→ 6,000,000 total
Exercise: $0.11From: 2010-12-30Exp: 2020-12-30→ Common (6,000,000 underlying)
Other
Common
2010-07-27+1,000,000→ 8,745,002 total
AwardSwap
Common
2010-12-29$0.11/sh+6,000,000$660,000→ 18,000,000 total
Exercise: $0.11From: 2012-01-03Exp: 2020-12-30→ Common (6,000,000 underlying)
AwardSwap
Stock Option
2010-12-29$0.11/sh+6,000,000$660,000→ 12,000,000 total
Exercise: $0.11From: 2011-06-30Exp: 2020-12-30→ Common (6,000,000 underlying)
AwardSwap
Stock Option (right to buy)
2012-05-19$0.51/sh+2,000,000$1,020,000→ 20,000,000 total
Exercise: $0.51From: 2012-11-18Exp: 2022-11-18→ Commom (2,000,000 underlying)

Holdings

common
(indirect: By Spouse)
2,752,310
Common
(indirect: Daughter)
749,972

Footnotes (2)

[F1]1,000,000 shares was transferred by The Menon Family Trust
[F2]Options were issued to Mr. Ehrlich in connection with renegotiating the terms of the outstanding loan balance as of March 31, 2012 of $2,248,037 represented by the Ehrlich Promissory Note C.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Cellceutix CORP

CIK 0001355250

Entity typeother

Related Parties

1

filerCIK 0001288099

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 12:27 PM ET
Size: 14.7 KB

View on SEC.gov